EGFR and non-small cell lung carcinoma: In addition, CNS metastases develop in around half of patients with mutant epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase-rearranged non-small-cell lung cancer, suggesting these genetic alterations are involved in neurotropic secondary tumors [92].